Click any annotated section or its icon to see analysis.
Section 1
1. Short title This Act may be cited as the Ensuring Access to Essential Drugs Act.
Section 2
2. Exempting certain drugs from the part D manufacturer discount program under the Medicare program Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended— in subparagraph (A), by striking and at the end; in subparagraph (B), by striking the period and inserting ; and; and by adding at the end the following new subparagraph: does not include an orally administered drug— for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services. (C)does not include an orally administered drug—(i)for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and(ii)that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services..